113. 筋ジストロフィー Muscular dystrophy Clinical trials / Disease details

臨床試験数 : 622 / 薬物数 : 485 - (DrugBank : 99) / 標的遺伝子数 : 59 - 標的パスウェイ数 : 168

3 trials found

diseases per page:

Showing 1 to 3 of 3 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2006-006776-37-NL (EUCTR)	14/05/2007	22/12/2006	Towards the assessment of metabolic biomarkers and creatineuptake and turnover in skeletal muscles o ...	Towards the assessment of metabolic biomarkers and creatineuptake and turnover in skeletal muscles o ...	Healthy volunteers. Later the protocol will be applied to Facioscapular humeral dystrophy and/or oth ...	Product Name: creatine -13C Product Code: Cr13C	Radboud University Nijmegen Medical Center	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes			Netherlands
2	NCT00018109 (ClinicalTrials.gov)	June 2001	3/7/2001	A Multicenter Randomized Placebo-Controlled Double-Blind Study to Assess Efficacy and Safety of Glut ...	A Multicenter Randomized Placebo-Controlled Double-Blind Study to Assess Efficacy and Safety of Glut ...	Muscular Dystrophy, Duchenne	Drug: glutamine;Drug: creatine monohydrate	National Center for Research Resources (NCRR)	Children's Research Institute	Completed	5 Years	10 Years	Male		Phase 3	United States
3	NCT00016653 (ClinicalTrials.gov)	June 2000	21/5/2001	Creatine and Glutamine in Steroid-Naive Duchenne Muscular Dystrophy	A Multicenter Randomized Placebo-controlled Double-blind Study to Assess Efficacy and Safety of Glut ...	Muscular Dystrophy, Duchenne	Drug: Creatine Monohydrate;Drug: Glutamine	Cooperative International Neuromuscular Research Group	NULL	Completed	5 Years	9 Years	Male	48	Phase 2/Phase 3	United States;Belgium;Israel;Puerto Rico

First Previous1Next Last